You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Drugs in ATC Class L01E

✉ Email this page to a colleague

« Back to Dashboard

Up to Top Level ATC Classes

Up to L - Antineoplastic and immunomodulating agents

Up to L01 - ANTINEOPLASTIC AGENTS

Subclasses in ATC: L01E - PROTEIN KINASE INHIBITORS drug patent expirations, market exclusivity, and generic launch dates

L01EA - BCR-ABL tyrosine kinase inhibitors

L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

L01EC - B-Raf serine-threonine kinase (BRAF) inhibitors

L01ED - Anaplastic lymphoma kinase (ALK) inhibitors

L01EE - Mitogen-activated protein kinase (MEK) inhibitors

L01EF - Cyclin-dependent kinase (CDK) inhibitors

L01EG - Mammalian target of rapamycin (mTOR) kinase inhibitors

L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors

L01EJ - Janus-associated kinase (JAK) inhibitors

L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors

L01EL - Bruton's tyrosine kinase (BTK) inhibitors

L01EM - Phosphatidylinositol-3-kinase (Pi3K) inhibitors

L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors

L01EX - Other protein kinase inhibitors

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.